MathewACherianMD

PubMed

• The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer.
  Jasmine M Manouchehri, Jharna Datta, Lynn M Marcho, Jesse J Reardon, Daniel Stover
  Breast Cancer Research. 2024-11-06
• The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer.
  Kai C C Johnson, Ai Ni, Dionisia Quiroga, Ashley C Pariser, Preeti K Sudheendra
  NPJ Breast Cancer. 2024-06-19
• Real-world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer.
  Jasmine S Sukumar, Sagar Sardesai, Andy Ni, Nicole Williams, Kai Johnson
  Cancer Medicine. 2024-06-01

Journal Articles

• An Activating Mutation of Interferon Regulatory Factor 4 (IRF4) in Adult T Cell Leukemia  
  Cherian MA, Olson S, Sundaramoorthi H, Cates K, Cheng X, Harding J, Martens A, Challen GA, Tyagi M, Ratner L, Rauch D, J Biol Chem, 1/14/2018
• The Role of Neratinib in HER2 Driven Breast Cancer  
  Cherian MA, Ma CX, Future Oncol, 1/20/2017
• A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndrome  
  Cherian MA, Tibes R, Gao F, Fletcher T, Fiala M, Uy GL, Westervelt P, Jacoby MA, Cashen AF, Stockerl-Goldstein K, DiPersio JF, Vij R, Leuk Lymphoma, 1/1/2016
• Inducible nitric oxide synthase mediates DNA double strand breaks in Human T-Cell Leukemia Virus Type 1-induced Leukemia/lymphoma  
  Baydoun H, Cherian MA, Green P, Ratner L, Retrovirology, 1/1/2015
• Akt Pathway Activation by Human T-cell Leukemia Virus Type 1 Tax Oncoprotein  
  Cherian M, Baydoun H, Al-Saleem J, Shkriabai N, Kvaratskhelia M, Green P, Ratner L, J Biol Chem, 1/1/2015
• Neratinib in Early-Stage HER2-Positive Breast Cancer  
  Mathew A. Cherian, Cynthia X. Ma., Breast Diseases: A Year Book Quarterly, 1/1/2015
• The Role of Saturation of Fat Depots in the Pathogenesis of Insulin Resistance  
  Cherian MA, Thomas J Santoro, Medical Hypotheses, 1/1/2006
• Biochemical and clinical profile after organophosphorus poisoning--a placebo-controlled trial using pralidoxime  
  Cherian MA, Roshini C, Visalakshi J, Jeyaseelan L, Cherian AM, J Assoc Physicians India, 1/1/2005
• Join now to see all